Table 5.
Description of the events | Number of patients (%) |
---|---|
Any adverse events | 24 (22.6%) |
Any serious adverse events | 0 |
Infusion reactions | 22 (20.8%) |
Fever or chills | 7 (6.6%) |
Primarily chest pain | 0 |
Dyspnea | 0 |
Myalgia | 4 (3.8%) |
Pruritus/rash | 8 (7.5%) |
Nausea/vomiting | 3 (2.8%) |
Anaphylaxis | 0 |
Seizures | 0 |
Hypotension | 0 |
Infections | 0 |
Hepatotoxicity | 2 (1.9%) |
Lupus-like syndrome | 0 |
Psoriasiform rash | 0 |
Deaths | 0 |